Financials

  • Market Capitalization 9.8 B
  • Employee 295
  • Founded 2016
  • CEO N/A
  • Website www.krystalbio.com
  • Headquarter Pennsylvania, United States
  • FIGI BBG00HDGRHH7
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
36.04
Índice preço/fluxo de caixa
18.98

Related tickers

#NomePreços24h %7d %1M %1A %Capitalização de mercadoÚltimos 7 dias
859
BMRN
BioMarin Pharmaceutical Inc. - Common Stock
55.45 USD+1.19%-2.89%-16.62%+5.92%10.73 B USD
890
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
80.35 USD+0.71%+4.80%+3.16%+102.67%10.22 B USD
931
KYMR
Kymera Therapeutics, Inc. - Common Stock
112.82 USD+0.37%+7.54%-2.74%+90.90%9.38 B USD
933
PTGX
Protagonist Therapeutics, Inc. - Common Stock
148.33 USD+3.20%+6.38%-1.06%+97.43%9.60 B USD

Notícias